US

U.S. Physical Therapy, Inc.

USPHHealthcareNASDAQ

Medical Care Facilities · Last scanned Oct 24, 2026

PriceMA150MA200
Loading chart…
End-of-day data · ScananceOpen live chart on TradingView ↗
Indicator snapshot · Today
Premium
Today's indicator reading is locked

Free plan shows historical signals only. Upgrade to see this ticker's current MA150, MA200, RSI, and MACD readings.

Upgrade to see today →
Financials · Annual
Revenue
$781.0M
+16.3% YoY
Net Income
$15.1M
-43.1% YoY
EBITDA
$109.7M
+26.2% YoY
Free Cash Flow
$41.3M

Scan Results

Daily timeframe
2 recent days hidden. Fresh signals are a Premium featureUpgrade →
DateIndicatorDetails
Oct 7▼ MACD Negative CrossoverHistogram -0.1620, negative momentum
Oct 6▼ MACD Negative CrossoverHistogram -0.0857, negative momentum
About U.S. Physical Therapy, Inc.

Part of the healthcare sector, U.S. Physical Therapy, Inc. (USPH) is listed under Medical Care Facilities. The company carries a $1.32B market cap, placing it firmly in the small-cap category. It operates through two segments, Physical Therapy Operations and Industrial Injury Prevention Services.

Where USPH stands vs its 150-day and 200-day moving averages

As of the October 7, 2026 close, USPH finished 13.92% above its 150-day moving average ($73.41) and 10.74% above its 200-day moving average ($75.52). This snapshot is end-of-day data shown with a five-trading-day delay on the free plan; Premium members see readings from the latest close.

Is USPH overbought or oversold?

At the October 7, 2026 close, USPH's RSI(14) was 51.1, in neutral territory (between 30 and 70). The MACD histogram was negative, so short-term momentum leaned bearish at that close. These readings are historical, refresh daily after market close, and are not investment advice.

Key stats
Market Cap$1.32B
P/E (TTM)491.83
Fwd P/E26.43
EPS$0.18
Beta1.11
52W Change-5.0%
Dividend Yield2.08%
ROE6.5%
Analysis

U.S. Physical Therapy, Inc. carries $385.8M in total debt against $26.3M in cash reserves — debt is roughly 14.7x the cash position. Managing this leverage effectively will be important for long-term financial stability. The company generates $41.3M in free cash flow annually, which funds everything from R&D to shareholder returns without needing external financing. Return on equity stands at 6.5%, which is modest for the sector. ROE measures how effectively a company uses shareholder capital to generate profits. ROA of 4.1% is on the lower side, which is common in asset-heavy industries. Revenue has grown from $553.1M (2022) to $781.0M (2025), reflecting a 41% increase over the period.

U.S. Physical Therapy, Inc. carries a heavier debt load relative to its cash position, which introduces financial risk that investors should weigh. At over 50x earnings, USPH carries valuation risk — any slowdown in growth expectations could lead to meaningful price adjustments. Understanding these risk dimensions helps frame what to watch going forward as conditions evolve for U.S. Physical Therapy, Inc. and its sector.

Links
More Healthcare stocks
Browse all stocks →
⚠Not financial advice. Scanance shows end-of-day technical indicators (not real-time prices) for information only. Results can be wrong; past performance does not guarantee future results.PrivacyTerms